Back to search

Article

KDM5A/B promotes HIV-1 latency and KDM5 inhibitors promote HIV-1 lytic reactivation

2022-11-17

Abstract excerpt

Combinational antiretroviral therapy (cART) effectively suppresses HIV-1 infection, replication, and pathogenesis in HIV-1 patients. However, the patient’s HIV-1 reservoir still cannot be eliminated by current cART or other therapies. One putative HIV-1 eradication strategy is “shock and kill”, which reactivates HIV-1 in latently-infected cells and induces their cytopathic effect or immune clearance to decrease th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bda398d5-e3a6-5a4e-ae55-1943ea21f62a
DOI
10.1101/2022.11.17.516956
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
KDM5A/B promotes HIV-1 latency and KDM5 inhibitors promote HIV-1 lytic reactivationDOI 10.1101/2022.11.17.516956
Select a neighboring publication to make it the new centre.